Skip to content

Cannabinoid Screening in Serum/Plasma

Published: August 9, 2026Updated: August 15, 2026

This test checks for the presence of certain cannabinoid compounds, including THC (tetrahydrocannabinol) and its metabolites, in your blood. It helps determine recent or past cannabis use.

Quick summary

["Detects recent cannabis exposure through measurable metabolites in your blood."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 15, 2026Editorial policy

Key facts at a glance

LOINC
8172-9
Short code
CANN
Synonyms
Cannabinoids SerPl Ql Scn
Category
chemistry
Sample
serum
Container
Red-top tube (no anticoagulant) for serum; or plasma separator tube (PST) with lithium heparin
Units
N/A
Ref low
10
Ref high
50
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
screen
CPT
G0434 (drug screen, other than chromatographic; any number of drug classes, by CLIA waived test or moderate complexity test) or 80307 (drug screen, presumptive) depending on payer
SNOMED
272218003
Specimen volume
3-5 mL of whole blood
Stability
Serum/plasma stable for 24 hours at room temperature, 7 days at 2-8°C, and up to 30 days frozen at -20°C or colder
Hemolysis max
100
Lipemia max
100
Icterus max
50
TAT
4–24 hours
Order
routine

What This Test Measures

Cannabinoid screening typically includes detection of THC and its primary metabolite, 11-nor-9-carboxy-THC (THC-COOH). These compounds are found in your blood after cannabis use and can persist for varying periods depending on frequency and amount consumed. The test may also include other cannabinoids like CBD (cannabidiol) if specified.

Why It’s Ordered

Doctors may order this test for suspected cannabis use in patients with symptoms like altered mental status, impaired coordination, or for legal, workplace, or pre-employment screening purposes. It can also be used in medical contexts to assess substance use disorders or monitor treatment responses.

Sample Collection and Preparation

A blood sample is drawn from a vein, usually in your arm. The blood is processed to separate serum or plasma, which is then analyzed for cannabinoid compounds. This test is typically performed on fresh or stored serum/plasma samples.

Test Method and Limitations

The test uses immunoassay methods (such as enzyme-linked immunosorbent assay, or ELISA) to detect cannabinoids. While highly sensitive, results can be influenced by factors like recent cannabis use, metabolism differences, or potential cross-reactivity with other substances. False positives may occur if other cannabinoid-like compounds are present.

Reference range

Negative (cutoff typically 10-50 ng/mL depending on laboratory and assay)N/A

Specimen: serum

No special preparation required. Patients should be advised that this is a screening test and that positive results require confirmatory testing. Informed consent may be required depending on state laws and testing circumstances.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Positive results indicate recent cannabis exposure and can guide treatment decisions, such as counseling or medical management for substance use disorders. Negative results suggest no detectable cannabinoids were present at the time of testing. Interpretation should always be done by a healthcare provider considering clinical context, patient history, and potential confounding factors.

Short name

Cannabinoid Screen

Frequently asked questions

How long does it take to get results?
Results are usually available within 1 to 3 business days, depending on laboratory processing times. Your healthcare provider will contact you once results are ready.
Can I drink alcohol before this test?
Alcohol does not interfere with cannabinoid testing, but avoid consuming alcohol or other substances that could affect your health or test accuracy. Follow your healthcare provider’s specific instructions for fasting or other preparations.
What if my results are positive?
A positive result means cannabinoids were detected in your blood. Your doctor will discuss next steps, which may include retesting, further evaluation, or referral to a specialist if substance use concerns are suspected. Always consult your healthcare provider for personalized guidance.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 15, 2026. · Read our editorial policy